Filing identity and reporting period
Important entity mismatch: The supplied filing is Genesis Park Acquisition Corp.’s Form 10-Q, not a Redwire Corp. filing. It covers July 29, 2020 (inception) through September 30, 2020; the report was signed January 7, 2021.
Genesis Park was a newly formed blank-check company seeking a business combination. It had not selected a target or begun substantive target discussions by the filing date. The company reported no operating activity through September 30; its activity consisted of formation and IPO preparation.
Financial results and position
- Revenue: None. The company said it did not expect operating revenue until after a business combination, at the earliest.
- Expenses and profit: Formation costs and net loss were $5,111. Basic and diluted loss per share was reported as $(0.00). No meaningful operating margin comparison is available.
- Assets and liquidity at September 30: Total assets were $262,530, comprising $146 cash and $262,384 deferred offering costs. The balance sheet lists $146 cash, although MD&A says the company had “no cash”; the filing text does not reconcile this inconsistency.
- Liabilities: Current liabilities totaled $242,641: $177,641 accrued offering costs and expenses, $35,000 due to a related party, and a $30,000 related-party promissory note. Shareholders’ equity was $19,889.
- Cash flow: Net cash used in operating activities was zero. Financing activities provided $146, including $30,000 of related-party note proceeds and $29,854 of deferred offering cost payments.
- Debt and commitments: The $30,000 sponsor note and $35,000 related-party balance were repaid on November 27, 2020. No working-capital loans were outstanding at September 30. The company reported no off-balance-sheet arrangements or contractual obligations at that date.
Material subsequent events and changes
After quarter-end, Genesis Park completed its IPO on November 27, 2020, selling 16,377,622 units at $10 each for gross proceeds of $163.8 million. It also raised $7.7 million through private warrant placements. Transaction costs were $9.6 million, including $5.7 million in deferred underwriting commissions. The company placed $166.2 million in a trust account and reported $1.3 million outside the trust for working capital as of the IPO closing.
The underwriter partially exercised its over-allotment option. Founder-share forfeitures and surrenders resulted in 4,094,406 Class B shares outstanding after the December 8, 2020 surrender. These IPO and share events occurred after the reporting date and should not be confused with September 30 balances.
Outlook, risks, and other matters
- The company had up to 18 months from the November 27, 2020 IPO closing to complete a business combination; otherwise, it generally must redeem public shares and liquidate.
- Management said it expected available funds to cover anticipated operating needs, but warned actual target-search, due-diligence, or transaction costs could exceed estimates and require additional financing. No successful business combination was assured.
- Management said COVID-19 could negatively affect financial position, operations, or the search for a target, but the specific impact was not determinable.
- Trust funds were to be invested in short-term U.S. government securities or qualifying money-market funds. The company reported no material market or interest-rate exposure at September 30.
- Management concluded disclosure controls were effective and reported no material change in internal control over financial reporting. No legal proceedings were reported.
Investor verification priorities
- Confirm the filing is the intended document: it is for Genesis Park Acquisition Corp., not Redwire Corp.
- Reconcile the $146 cash balance with MD&A’s statement that the company had no cash.
- Verify IPO proceeds, trust funding, fees, and post-quarter cash against subsequent filings.
- Review the business-combination deadline, redemption mechanics, potential dilution from warrants and founder shares, and any later target or financing developments.
- Assess the effect of COVID-19 and any changes in the company’s disclosed risks after this filing.